Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Elife|February 17, 2025
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscapeAshley L Cook, Surojit Sur, Laura Dobbyn, et al.Cancer Research Communications|March 18, 2025
A Blood-Based Assay for Detection of Patients with Advanced AdenomasKamel Lahouel, Christopher Douville, Brenda Diergaarde, et al.Proceedings of the National Academy of Sciences of the United States of America|April 4, 2023
Detection of rare mutations, copy number alterations, and methylation in the same template DNA moleculesYuxuan Wang, Christopher Douville, Joshua D Cohen, et al.Proceedings of the National Academy of Sciences of the United States of America|February 21, 2020
Assessing aneuploidy with repetitive element sequencingChristopher Douville, Joshua D Cohen, Janine Ptak, et al.JAMA Oncology|October 18, 2019
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon CancerJeanne Tie, Joshua D Cohen, Yuxuan Wang, et al.Cancer Discovery|August 11, 2023
The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian CancerAustin K Mattox, Christopher Douville, Yuxuan Wang, et al.International Journal of Cancer|September 28, 2020
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studiesJeanne Tie, Joshua D Cohen, Serigne N Lo, et al.Nature Medicine|March 7, 2025
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trialJeanne Tie, Yuxuan Wang, Serigne N Lo, et al.The New England Journal of Medicine|June 3, 2022
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon CancerJeanne Tie, Joshua D Cohen, Kamel Lahouel, et al.Nature Medicine|October 20, 2025
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trialJeanne Tie, Yuxuan Wang, Jonathan M Loree, et al.Pageof 4